神经退行性疾病中的补充系统
Jacqui Nimmo1, Robert A J Byrne1, Nikoleta Daskoulidou1
1UK Dementia Research Institute Cardiff, Cardiff University, Cardiff CF24 4HQ, U.K.
Clinical science (London, England : 1979)
|March 20, 2024
概括
补体系统驱动神经系统疾病的炎症,如阿尔茨海默病,帕金森病,精神分裂症和多发性硬化症. 向补充剂可能为这些疾病提供新的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
背景情况:
- 补体系统对于天生的免疫力和清除免疫复合体至关重要.
- 适当调节补充介导炎症对于其保护功能至关重要.
- 不调节的补充激活有助于各种疾病的病理性炎症,包括神经系统疾病.
研究的目的:
- 审查涉及神经退行性疾病中补充系统的证据.
- 专注于阿尔茨海默病,帕金森病,精神分裂症和多发性硬化症.
- 简要讨论反补充药物的治疗潜力和挑战.
主要方法:
- 关于研究补充剂在神经疾病中的作用的文献综述.
- 分析证据,将补充激活与疾病病理学联系起来.
- 讨论潜在的抗补剂药物治疗方法.
主要成果:
- 越来越多的证据表明补充系统与神经炎症和神经退行性疾病有关.
- 补充在阿尔茨海默病,帕金森病,精神分裂症和多发性硬化症中起作用.
- 神经退行是这些不同的神经疾病的重要特征.
结论:
- 补体系统是多种神经疾病病理学的关键驱动因素.
- 准补充系统为神经退行性疾病提供了潜在的治疗策略.
- 需要进一步的研究才能充分了解抗补剂疗法的治疗潜力和陷.
相关概念视频
Complement System
2.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.4K
Role of Neurotransmitters in Memory
548
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
548
Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Disorders of the Nervous Tissue
1.3K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.3K
The Blood-brain Barrier
47.3K
Overview
47.3K


